GS0051: Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of cancer; medicines for human purposes, namely, for treating genetically based diseases and disorders
Case File Event Statements
3/3/2023 - a year ago
1 - NEW APPLICATION ENTEREDType:NWAP
3/20/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
11/28/2023 - a year ago
3 - ASSIGNED TO EXAMINERType:DOCK
12/11/2023 - a year ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/16/2024 - 11 months ago
6 - PUBLISHED FOR OPPOSITIONType:PUBO
12/27/2023 - a year ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
1/16/2024 - 11 months ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
3/12/2024 - 9 months ago
8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
4/3/2024 - 9 months ago
9 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
8/9/2024 - 4 months ago
10 - SOU TEAS EXTENSION RECEIVEDType:EEXT
8/9/2024 - 4 months ago
13 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA